EA201001408A1 - Производные пиразинона как стимуляторы секреции инсулина, способы их получения и их применение для лечения диабетов - Google Patents

Производные пиразинона как стимуляторы секреции инсулина, способы их получения и их применение для лечения диабетов

Info

Publication number
EA201001408A1
EA201001408A1 EA201001408A EA201001408A EA201001408A1 EA 201001408 A1 EA201001408 A1 EA 201001408A1 EA 201001408 A EA201001408 A EA 201001408A EA 201001408 A EA201001408 A EA 201001408A EA 201001408 A1 EA201001408 A1 EA 201001408A1
Authority
EA
Eurasian Patent Office
Prior art keywords
derivatives
insulin secretion
pyrazinon
methods
receiving
Prior art date
Application number
EA201001408A
Other languages
English (en)
Other versions
EA021325B1 (ru
Inventor
Жерар Боттон
Мишлине Кегоат
Кристине Шарон
Самер Эльбаваб
Original Assignee
Мерк Патент Гмбх
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Мерк Патент Гмбх filed Critical Мерк Патент Гмбх
Publication of EA201001408A1 publication Critical patent/EA201001408A1/ru
Publication of EA021325B1 publication Critical patent/EA021325B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/06—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members
    • C07D241/08—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/18—Oxygen or sulfur atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Настоящее изобретение относится к производным пиразинона формулы (I)где n, R1, R2, R3 и R4 являются такими, как определено в п.1, как стимуляторам секреции инсулина. Изобретение также относится к получению и применению этих производных пиразинона для профилактики и/или лечения диабетов и связанных патологий.
EA201001408A 2008-03-05 2009-01-15 Производные пиразинона как стимуляторы секреции инсулина, способы их получения и их применение для лечения диабетов EA021325B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08004193 2008-03-05
PCT/EP2009/000213 WO2009109259A1 (en) 2008-03-05 2009-01-15 Pyrazinone derivatives as insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes

Publications (2)

Publication Number Publication Date
EA201001408A1 true EA201001408A1 (ru) 2011-06-30
EA021325B1 EA021325B1 (ru) 2015-05-29

Family

ID=40565210

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201001408A EA021325B1 (ru) 2008-03-05 2009-01-15 Производные пиразинона как стимуляторы секреции инсулина, способы их получения и их применение для лечения диабетов

Country Status (18)

Country Link
US (2) US8637522B2 (ru)
EP (1) EP2250156B1 (ru)
JP (1) JP5530370B2 (ru)
KR (1) KR101637381B1 (ru)
CN (1) CN101945858B (ru)
AR (1) AR070798A1 (ru)
AU (1) AU2009221328B2 (ru)
BR (1) BRPI0908544A2 (ru)
CA (1) CA2717753C (ru)
DK (1) DK2250156T3 (ru)
EA (1) EA021325B1 (ru)
ES (1) ES2543598T3 (ru)
HU (1) HUE025132T2 (ru)
IL (1) IL207719A (ru)
MX (1) MX2010009575A (ru)
PT (1) PT2250156E (ru)
WO (1) WO2009109259A1 (ru)
ZA (1) ZA201007060B (ru)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011107494A1 (de) 2010-03-03 2011-09-09 Sanofi Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung
US8530413B2 (en) 2010-06-21 2013-09-10 Sanofi Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
TW201221505A (en) 2010-07-05 2012-06-01 Sanofi Sa Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament
TW201215388A (en) 2010-07-05 2012-04-16 Sanofi Sa (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments
TW201215387A (en) 2010-07-05 2012-04-16 Sanofi Aventis Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
CN102260268B (zh) * 2011-06-19 2013-04-03 漆又毛 苄硫基乙酰胺基乙酰吡嗪三唑衍生物及制备与应用
WO2013037390A1 (en) 2011-09-12 2013-03-21 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
WO2013045413A1 (en) 2011-09-27 2013-04-04 Sanofi 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH609989A5 (en) * 1974-06-21 1979-03-30 Hoffmann La Roche Process for the preparation of acyl derivatives
EP0008864A1 (en) * 1978-08-15 1980-03-19 FISONS plc Pyridopyrazine and quinoxaline derivatives, processes for their preparation, and pharmaceutical compositions containing them
EP0927171B1 (en) 1996-09-16 2002-02-20 Du Pont Pharmaceuticals Company Pyrazinones and triazinones and their derivatives thereof
CA2626220A1 (en) * 2005-12-21 2007-06-28 Janssen Pharmaceutica N.V. Novel substituted pyrazinone derivatives for use in mch-1 mediated diseases
US20090011994A1 (en) * 2007-07-06 2009-01-08 Bristol-Myers Squibb Company Non-basic melanin concentrating hormone receptor-1 antagonists and methods

Also Published As

Publication number Publication date
BRPI0908544A2 (pt) 2015-09-29
CN101945858B (zh) 2014-05-21
EA021325B1 (ru) 2015-05-29
PT2250156E (pt) 2015-09-09
HUE025132T2 (en) 2016-01-28
US8637522B2 (en) 2014-01-28
MX2010009575A (es) 2010-09-24
JP2011513344A (ja) 2011-04-28
IL207719A0 (en) 2010-12-30
WO2009109259A1 (en) 2009-09-11
IL207719A (en) 2015-05-31
JP5530370B2 (ja) 2014-06-25
EP2250156A1 (en) 2010-11-17
KR20100123900A (ko) 2010-11-25
CA2717753C (en) 2016-09-13
AR070798A1 (es) 2010-05-05
DK2250156T3 (en) 2015-08-03
ES2543598T3 (es) 2015-08-20
US20140100235A1 (en) 2014-04-10
CN101945858A (zh) 2011-01-12
US20110015210A1 (en) 2011-01-20
ZA201007060B (en) 2011-06-29
CA2717753A1 (en) 2009-09-11
EP2250156B1 (en) 2015-05-06
AU2009221328A1 (en) 2009-09-11
KR101637381B1 (ko) 2016-07-07
AU2009221328B2 (en) 2014-02-27
US9102632B2 (en) 2015-08-11

Similar Documents

Publication Publication Date Title
EA201001407A1 (ru) Производные хиноксалинона в качестве стимуляторов секреции инсулина, способы их получения и их применение для лечения диабета
EA201001408A1 (ru) Производные пиразинона как стимуляторы секреции инсулина, способы их получения и их применение для лечения диабетов
EA201070422A1 (ru) Производные оксадиазола
EA201200952A1 (ru) Производные пиразина и их применение для лечения неврологических нарушений
EA201000105A1 (ru) Химические соединения
EA201100007A1 (ru) Производные хиноксалиндиона
UA98961C2 (ru) Производные пиразинона и их применение в лечении легочных заболеваний
EA200800172A1 (ru) 2,4-диаминопиримидины как ингибиторы aurora
MA32544B1 (fr) Derives de pyridino-pyridinones, leur preparation et leur application en therapeutique
EA201190217A1 (ru) Замещенные 2-ацетамидо-5-арил-1,2,4-триазолоны и их применение
EA201071045A1 (ru) Соединения оксадиазоантрацена для лечения диабета
EA201200174A1 (ru) Производные оксазина и их применение в качестве ингибиторов bace для лечения неврологических нарушений
EA201100564A1 (ru) Антипролиферативные соединения
EA201200176A1 (ru) Производные оксазина и их применение для лечения неврологических нарушений
EA200701471A1 (ru) Замещённые пиридинильные и пиримидинильные производные, используемые в качестве модуляторов метаболизма и лечение ассоциированных с ним расстройств
EA200800555A1 (ru) Производные ксантина в качестве селективных агонистов hm74a
EA201001358A1 (ru) Активаторы глюкокиназы
TW200606162A (en) Pyrazolopyridine derivatives
TW200745004A (en) Novel compounds, their preparation and use
EA201100794A1 (ru) Замещенные пиримидины, предназначенные для лечения заболеваний, таких как рак
DE502006006107D1 (de) Amid substituierte 8-n-benzimidazole, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
MY149648A (en) Carboxylalkylene-phenyl)-phenyl-oxalamides, method for the production thereof, and use of same as a medicament
EA201100255A1 (ru) 5-алкинилпиримидины
EA201171210A1 (ru) Производные оксадиазола
EA200971107A1 (ru) Катехоламиновые производные, полезные для лечения болезни паркинсона

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM